Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Research output
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
A Phase 1 Study of Oral LY3410738 in Patients with Advanced Hematologic Malignancies with IDH1 or IDH2 Mutations.
Wei, Andrew
(Chief Investigator (CI))
Kennedy, Nola
(Project Manager)
Bajel, Ashish
(Chief Investigator (CI))
Flemming, Shaun
(Primary Chief Investigator (PCI))
Australian Centre for Blood Diseases
Alfred Health
Royal Melbourne Hospital
Peter MacCallum Cancer Centre
Alfred Hospital
Monash University
Project
:
Research
Overview
Project Details
Status
Active
Effective start/end date
2/12/20
→
31/12/25
View all
View less
Keywords
Malignant Haematology
Clinical trial